Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Rob Isbitts

Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Go beyond the broad index and find which segment of healthcare best suits your portfolio needs now.

Rising Rates Are Threatening to Kill the Zombies and Send Small-Cap Stocks Plunging

Rising Rates Are Threatening to Kill the Zombies and Send Small-Cap Stocks Plunging

A consequential threat to the market is quietly developing in fixed income.

Why the Earnings Report Reaction in Nvidia Stock Matters So Much More This Time

The entire financial complex is currently hanging by a thread. Or rather, a microchip.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Consumer Staples Are Losing Their Safe-Haven Status. Here's Why.

There’s a large camp among Wall Street analysts that assumes when the technology and other growth sectors plunge, the safety trade is in consumer staples. Here's why that might be changing.

The $43 Billion ETF Hiding in Plain Sight. Why DIA Might Outperform SPY and QQQ for the Rest of 2026.

If the market maintains its all-time highs, DIA is poised to catch up as investors seek out the relatively cheaper pockets of the large-cap universe.

The VIX and SPY Are Falling at the Same Time. Don’t Get Trapped by Volatility Hiding in a Market Blind Spot.

Just because the VIX is falling does not mean there is no volatility. It is just hiding where traders are not looking now.

These 3 AI ETFs Could Be the First to Kill the Stock Market Rally

The alarm bells are not ringing yet, but keep your ears open.

inkl

Read news from The Economist, FT, and more,
with one subscription

Colgate-Palmolive May Be Boring, But CL Stock Has Great Upside Potential Here

Colgate-Palmolive May Be Boring, But CL Stock Has Great Upside Potential Here

Colgate-Palmolive (CL) shares are making the most of the latest market attempt to broaden. The stock currently maintains a 56% “BUY” technical opinion from Barchart, as short-term momentum indicators begin to turn constructive following a solid move up from April’s $82 bottom. CL is trading below its 52-week high of...

The Cerebras IPO Is a Clear Sign That the Stock Market Is ‘Wafer Thin’

The Cerebras IPO Is a Clear Sign That the Stock Market Is ‘Wafer Thin’

As a career investor, I am not buying into the Cerebras IPO hype.

1 Rapidly Deteriorating ETF Screams That ‘Shop ‘Til You Drop’ Americans Have All But Keeled Over

1 Rapidly Deteriorating ETF Screams That ‘Shop ‘Til You Drop’ Americans Have All But Keeled Over

The SPDR S&P Retail ETF (XRT) has long been the primary barometer for the health of the American consumer, and lately, the readings are turning decidedly cold.

Yield Is No Longer King: What These 5 Dividend ETFs Are Telling Investors

Yield Is No Longer King: What These 5 Dividend ETFs Are Telling Investors

Dividend investing has changed, and yield is misunderstood or misused by many investors. Let's take a closer look at 5 ETFS and discuss what dividend investors should know.

The DRAM ETF’s Record Success Warns of a Dot-Com Bubble Burst. We’re Just Waiting for the Explosion.

The DRAM ETF’s Record Success Warns of a Dot-Com Bubble Burst. We’re Just Waiting for the Explosion.

The higher the mountain, the more treacherous the backside. Thus, investors should be wary of treating a cyclical peak like this one as a permanent plateau.

Michael Burry Says the Stock Market Has ‘Jumped the Shark.’ If He’s Right, This ETF Will Be Your Chum.

Michael Burry Says the Stock Market Has ‘Jumped the Shark.’ If He’s Right, This ETF Will Be Your Chum.

This inverse ETF lets you profit from a major decline in the S&P 500.

Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.

Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.

A localized outbreak, even a fatal one, is unlikely to spark the multibillion-dollar revenue catalyst that Moderna needs.

Get all your
news in one place.

100's of premium titles.
One news app.

Bye Bye, Volatility: 1 Blockchain ETF to Watch Now as Bitcoin Prices Stabilize

The blockchain industry, often synonymous with extreme volatility and speculative excess, appears to be stabilizing.

Bigger Isn't Always Better: Why This Small-Cap ETF Is a Top Play for a Go-Go Stock Market

Too many investors are focused on large-caps when there's plenty to be interested in in the small-cap category. Let's take a closer look at one small-cap ETF to consider.

If You’re Still Buying Gold ETFs to Protect Against Inflation, Stop

Gold has long been sold as an inflation hedge. There is a much better reason to chase the precious metal and ETFs that track it.

U.S. Investors Should Be Jealous of the Historic Rate-Cut Cycle Happening in Mexico. Here’s 2 Ways to Profit.

These 2 ETFs offer savvy ways for investors to diversify away from an increasingly AI-focused U.S. market.

Get all your
news in one place.

100's of premium titles.
One news app.

Compute Spending Just Broke the Dot-Com Record High. Here’s the Safe Way to Invest in AI Now…. Just in Case.

In macro market analysis, there are milestones that act as flashing yellow lights. We just hit one.

These 3 Charts Look Like Thoroughbreds: Get Derby-Ready With My Racetrack-to-SPY Roadmap

Our resident ROAR columnist explains how he got into horse racing, and how stock market fans can find a favorite for this weekend.

Let’s Get This Strait: Ignore Energy Prices at Your Own Peril (and 3 ETFs to Buy Now)

In a market defined by geopolitical blocks and supply shocks, the winners are those who own the one thing the world can’t live without: Power.

Semiconductor Stocks Are the New Elephant in the Room at 14% of the S&P 500. How to Play This Tech Super-Sector.

The semiconductor industry group has ballooned to an unprecedented 14% of the S&P 500’s total market weight.

Dan Ives’ Latest AI ETF Goes Beyond the Mag 7, Focusing on the ‘Circulatory System’ of a Tech Revolution

IVEP is about the non-tech side of the mega-AI trade. As AI data centers grow, they are consuming power at a rate that traditional utilities can’t handle. IVEP might be a focused way for investors to capture the companies solving that specific power crisis.

Why Rambus Stock’s Post-Earnings Plunge Might Be a Canary in the Coal Mine for AI Stocks

In the blink of an eye, Rambus stock went from hitting new all-time highs to shedding more than one-fifth of its value overnight.

5 Magnificent 7 Stocks Report Earnings This Week. Here's What to Watch for Each.

When these five Magnificent 7 stocks report earnings this week, it will likely impact the entire market. Here's what to know.

1 2 3 4 5

People

Paul Tudor Jones

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

389,270 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play